24th Int'l Prostate Cancer Update: Poster - Efficacy and safety of radium-223 dichloride (radium-223) in patients who did or did not receive prior docetaxel in the phase 3 ALSYMPCA trial

VAIL, CO USA (UroToday.com) - Presented by Peter Hoskin, Mona Wahba, John Logue, David Bottomley, Sten Nilsson, Fang Fang, Jose Garcia-Vargas, Karin Staudacher, Paul Cislo, Jonathan Reuning-Scherer, and Christopher Parker at the 24th International Prostate Cancer Update - February 19 - 22, 2014 - Cascade Conference Center - Vail, Colorado USA

IPCU 2014 Hoskin thumb

Mount Vernon Hospital Cancer Centre, Middlesex, UK;
Bayer HealthCare, Whippany, NJ, USA;
Christie Hospital, Manchester, UK;
St. James Hospital, Leeds, UK;
Karolinska University Hospital, Stockholm, Sweden;
Algeta ASA, Oslo, Norway;
Yale University, New Haven, CT, USA;
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK
 

Click HERE to read the abstract from this session

 

 

email news signup